Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 17:00:29 GMT 2025
by
admin
on
Tue Apr 01 17:00:29 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
68L32FM3IQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P10828
Created by
admin on Tue Apr 01 17:00:29 GMT 2025 , Edited by admin on Tue Apr 01 17:00:29 GMT 2025
|
PRIMARY | |||
|
68L32FM3IQ
Created by
admin on Tue Apr 01 17:00:29 GMT 2025 , Edited by admin on Tue Apr 01 17:00:29 GMT 2025
|
PRIMARY | |||
|
P10828
Created by
admin on Tue Apr 01 17:00:29 GMT 2025 , Edited by admin on Tue Apr 01 17:00:29 GMT 2025
|
PRIMARY |
| Linkage Type | Residue Index | |
|---|---|---|
| ZINC FINGER | 1_107 | 1_127 |
| ZINC FINGER | 1_145 | 1_169 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
AGONIST -> TARGET |
Binds selectively to the main hepatic form of thyroid hormone (TH) receptor, TR?1, compared to TR?1, which is principally responsible for thyrotoxic effects on heart, muscle and bone.
|
||
|
AGONIST -> TARGET |
increased expression of the hepatic LDL-receptor gene
|
||
|
AGONIST -> TARGET | |||
|
PARTIAL AGONIST->TARGET |
28 times more selective to TR.beta. than TR.alpha. Emax= 83.8% of the maximum response compared to triiodothyronine (T3).
EC50
|
||
|
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
|
AGONIST -> TARGET |
|
||
|
MIMETIC->TARGET | |||
|
AGONIST -> TARGET |
Increased ABCD2 gene expression by 10-fold in X-ALD fibroblasts (4 nm)
EC50
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|